Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Chevron Corporation's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $409.2B | |
|---|---|---|
| Revenue (ttm) | 209.4B | |
| Net income (ttm) | 20.6B | |
| EPS (ttm) | $10.4 | |
| Shares out | 2B | |
| P/E (trailing) | 22.0x | |
| P/E (forward) | 15.8x | |
| Dividend | $7.12 (3.11%) | |
| Volume | 4,943,111 | |
| Beta | 0.52 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $155.61B | $235.72B | $196.91B | $193.41B | $184.43B | +4.3% |
| Gross profit | $45.43B | $73.98B | $60.39B | $56.93B | $56.09B | +5.4% |
| Operating income | $22.35B | $50.19B | $30.05B | $28.10B | $20.96B | -1.6% |
| Net income | $15.63B | $35.47B | $21.37B | $17.66B | $12.30B | -5.8% |
| EPS (diluted) | $8.14 | $18.28 | $11.36 | $9.72 | $6.63 | -5.0% |
| EBITDA | $39.36B | $66.49B | $47.82B | $45.81B | $41.42B | +1.3% |
| R&D | $268.0M | $268.0M | $320.0M | $353.0M | $427.0M | +12.4% |
| SG&A | $4.01B | $4.31B | $4.14B | $4.83B | $5.13B | +6.3% |
Recent company headlines from major financial publishers.
This remains the central path because later estimate increases improve the level but do not remove the FY2027 reversal. Non-contracting FY2027 revenue would disconfirm it.
Upward revisions would need to broaden beyond the near-term rebound. The case fades if earnings weaken or recurring investment absorbs more operating cash.
| Ke ↓ / g → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 4.9% | $202 | $216 | $235 | $264 | $309 |
| 5.9% | $174 | $182 | $192 | $206 | $224 |
| 6.9% | $155 | $160 | $170 | $174 | $183 |
| 7.9% | $141 | $144 | $148 | $153 | $159 |
| 8.9% | $129 | $132 | $135 | $138 | $142 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
